A genome-wide linkage study of bipolar disorder and co-morbid migraine: replication of migraine linkage on chromosome 4q24, and suggestion of an overlapping susceptibility region for both disorders on chromosome 20p11
- PMID: 19819557
- PMCID: PMC5660919
- DOI: 10.1016/j.jad.2009.06.014
A genome-wide linkage study of bipolar disorder and co-morbid migraine: replication of migraine linkage on chromosome 4q24, and suggestion of an overlapping susceptibility region for both disorders on chromosome 20p11
Abstract
Migraine and Bipolar Disorder (BPAD) are clinically heterogeneous disorders of the brain with a significant, but complex, genetic component. Epidemiological and clinical studies have demonstrated a high degree of co-morbidity between migraine and BPAD. Several genome-wide linkage studies in BPAD and migraine have shown overlapping regions of linkage on chromosomes, and two functionally similar voltage-dependent calcium channels CACNA1A and CACNA1C have been identified in familial hemiplegic migraine and recently implicated in two whole genome BPAD association studies, respectively. We hypothesized that using migraine co-morbidity to look at subsets of BPAD families in a genetic linkage analysis would prove useful in identifying genetic susceptibility regions in both of these disorders. We used BPAD with co-morbid migraine as an alternative phenotype definition in a re-analysis of the NIMH Bipolar Genetics Initiative wave 4 data set. In this analysis we selected only those families in which at least two members were diagnosed with migraine by a doctor according to patients' reports. Nonparametric linkage analysis performed on 31 families segregating both BPAD and migraine identified a linkage signal on chromosome 4q24 for migraine (but not BPAD) with a peak LOD of 2.26. This region has previously been implicated in two independent migraine linkage studies. In addition we identified a locus on chromosome 20p11 with overlapping elevated LOD scores for both migraine (LOD=1.95) and BPAD (LOD=1.67) phenotypes. This region has previously been implicated in two BPAD linkage studies, and, interestingly, it harbors a known potassium dependant sodium/calcium exchanger gene, SLC24A3, that plays a critical role in neuronal calcium homeostasis. Our findings replicate a previously identified migraine linkage locus on chromosome 4 (not co-segregating with BPAD) in a sample of BPAD families with co-morbid migraine, and suggest a susceptibility locus on chromosome 20, harboring a gene for the migraine/BPAD phenotype. Together these data suggest that some genes may predispose to both bipolar disorder and migraine.
Copyright 2009 Elsevier B.V. All rights reserved.
Conflict of interest statement
None.
Figures


Similar articles
-
A genome-wide association study of bipolar disorder and comorbid migraine.Genes Brain Behav. 2010 Oct;9(7):673-80. doi: 10.1111/j.1601-183X.2010.00601.x. Epub 2010 Jun 29. Genes Brain Behav. 2010. PMID: 20528957 Free PMC article.
-
An apparently dominant bipolar affective disorder (BPAD) locus on chromosome 20p11.2-q11.2 in a large Turkish pedigree.Eur J Hum Genet. 2001 Jan;9(1):39-44. doi: 10.1038/sj.ejhg.5200584. Eur J Hum Genet. 2001. PMID: 11175298
-
A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42.Mol Psychiatry. 2004 Dec;9(12):1083-90. doi: 10.1038/sj.mp.4001544. Mol Psychiatry. 2004. PMID: 15249933 Clinical Trial.
-
Update on the genetics of migraine.Hum Genet. 2004 Feb;114(3):225-35. doi: 10.1007/s00439-003-1055-9. Epub 2003 Nov 18. Hum Genet. 2004. PMID: 14624354 Review.
-
Genetic linkage and association studies in bipolar affective disorder: a time for optimism.Am J Med Genet C Semin Med Genet. 2003 Nov 15;123C(1):36-47. doi: 10.1002/ajmg.c.20012. Am J Med Genet C Semin Med Genet. 2003. PMID: 14601035 Review.
Cited by
-
Parental and comorbid migraine in individuals with bipolar disorder: A nationwide register study.J Affect Disord. 2016 Dec;206:109-114. doi: 10.1016/j.jad.2016.07.034. Epub 2016 Jul 19. J Affect Disord. 2016. PMID: 27472412 Free PMC article.
-
Confirmation that Xq27 and Xq28 are susceptibility loci for migraine in independent pedigrees and a case-control cohort.Neurogenetics. 2012 Feb;13(1):97-101. doi: 10.1007/s10048-011-0312-7. Neurogenetics. 2012. PMID: 22294494
-
Adult attention deficit hyperactivity disorder is associated with migraine headaches.Eur Arch Psychiatry Clin Neurosci. 2011 Dec;261(8):595-602. doi: 10.1007/s00406-011-0203-9. Epub 2011 Mar 11. Eur Arch Psychiatry Clin Neurosci. 2011. PMID: 21394551 Free PMC article.
-
Comorbid Bipolar Disorder and Migraine: From Mechanisms to Treatment.Front Psychiatry. 2021 Jan 11;11:560138. doi: 10.3389/fpsyt.2020.560138. eCollection 2020. Front Psychiatry. 2021. PMID: 33505322 Free PMC article. Review.
-
Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications.J Headache Pain. 2019 May 9;20(1):51. doi: 10.1186/s10194-019-0988-x. J Headache Pain. 2019. PMID: 31072313 Free PMC article.
References
-
- Abecasis GR, Cerny SS, Cookson WO, Cardon LR. Merlin: rapid analysis of dense genetic maps using sparse gene flow trees. Nat. Genet. 2002;30:97–101. - PubMed
-
- Akiskal HS, McKinney WT. Depressive disorders: toward a unified hypothesis. Science. 1973;182:20–29. - PubMed
-
- Anttila V, Kallela M, Oswell G, Kaunisto MA, Nyholt DR, Hamalainen E, Havanka H, Ilmavirta M, Terwilliger J, Sobel E, Peltonen L, Kaprio J, Farkkila M, Wessman M, Palotie A. Trait components provide tools to dissect the genetic susceptibility of migraine. Am. J. Hum. Genet. 2006;79(1):85–99. - PMC - PubMed
-
- Anttila V, Nyholt DR, Kallela M, Artto V, Vepsäläinen S, Jakkula E, Wennerström A, Tikka-Kleemola P, Kaunisto MA, Hämäläinen E, Widén E, Terwilliger J, Merikangas K, Montgomery GW, Martin NG, Daly M, Kaprio J, Peltonen L, Färkkilä M, Wessman M, Palotie A. Consistently replicating locus linked to migraine on 10q22–q23. Am. J. Hum. Genet. 2008;85(5):1051–1063. - PMC - PubMed
-
- Askland K, Parsons M. Toward a biaxial model of “bipolar” affective disorders: spectrum phenotypes as the products of neuroelectrical and neurochemical alterations. J. Affect. Disord. 2006;94:15–33. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 MH059556/MH/NIMH NIH HHS/United States
- R01MH59553/MH/NIMH NIH HHS/United States
- R01 MH059545/MH/NIMH NIH HHS/United States
- U01 MH46282/MH/NIMH NIH HHS/United States
- R01 MH068503/MH/NIMH NIH HHS/United States
- R01 MH059548/MH/NIMH NIH HHS/United States
- R01 MH59535/MH/NIMH NIH HHS/United States
- R01 MH085801/MH/NIMH NIH HHS/United States
- R01 MH073991/MH/NIMH NIH HHS/United States
- R01 MH060068/MH/NIMH NIH HHS/United States
- R01 MH059535/MH/NIMH NIH HHS/United States
- R01 MH59545/MH/NIMH NIH HHS/United States
- R01 MH059567/MH/NIMH NIH HHS/United States
- MH47612/MH/NIMH NIH HHS/United States
- R01 MH59533/MH/NIMH NIH HHS/United States
- Z01 MH002810/ImNIH/Intramural NIH HHS/United States
- 1Z01MH002810-01/MH/NIMH NIH HHS/United States
- MH073991/MH/NIMH NIH HHS/United States
- R01 MH059534/MH/NIMH NIH HHS/United States
- R01 MH60068/MH/NIMH NIH HHS/United States
- R01 MH059533/MH/NIMH NIH HHS/United States
- MH68503/MH/NIMH NIH HHS/United States
- MH59567/MH/NIMH NIH HHS/United States
- U01 MH092758/MH/NIMH NIH HHS/United States
- U01MH46274/MH/NIMH NIH HHS/United States
- R01 MH59567/MH/NIMH NIH HHS/United States
- U01 MH46280/MH/NIMH NIH HHS/United States
- R01 MH059553/MH/NIMH NIH HHS/United States